Cargando…

Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study

AIMS: The relationship between metformin therapy and the risk of coronavirus disease (COVID-19) has not been reported among patients with type 2 diabetes mellitus (DM). We aimed to investigate whether metformin therapy was associated with the incidence of COVID-19 among type 2 DM patients in South K...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Tak Kyu, Song, In-Ae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882044/ https://www.ncbi.nlm.nih.gov/pubmed/33582839 http://dx.doi.org/10.1007/s00592-020-01666-7

Ejemplares similares

Socioeconomic disparity and the risk of contracting COVID-19 in South Korea: an NHIS-COVID-19 database cohort study
por: Oh, Tak Kyu, et al.
Publicado: (2021)

Response to “Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study”
por: Kumar, Satesh, et al.
Publicado: (2022)

Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study
por: Oh, Tak Kyu, et al.
Publicado: (2021)

Intensivist coverage and critically ill COVID-19 patient outcomes: a population-based cohort study
por: Oh, Tak Kyu, et al.
Publicado: (2023)

Metformin is associated with favorable outcomes in patients with COVID-19 and type 2 diabetes mellitus
por: Ma, Zhiyuan, et al.
Publicado: (2022)

Statin Therapy and the Risk of COVID-19: A Cohort Study of the National Health Insurance Service in South Korea
por: Oh, Tak Kyu, et al.
Publicado: (2021)

Is metformin a miracle or a menace in COVID‐19 patients with type 2 diabetes?
por: Lui, David Tak Wai, et al.
Publicado: (2021)

The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus
por: Yang, Wenxing, et al.
Publicado: (2021)

Is there a need to reconsider the use of metformin in COVID-19 patients with type 2 diabetes mellitus?
por: Lazarus, Gilbert, et al.
Publicado: (2021)

The Phenomenon of Metformin in COVID-19 Pandemic Among Polish Patients with Type 2 Diabetes Mellitus
por: Mrozikiewicz-Rakowska, Beata, et al.
Publicado: (2021)

Evaluating the prevalence, awareness, and control of hypertension, diabetes, and dyslipidemia in Korea using the NHIS-NSC database: A cross-sectional analysis
por: Boo, Sunjoo, et al.
Publicado: (2018)

Comorbidities of nontuberculous mycobacteria infection in Korean adults: results from the National Health Insurance Service–National Sample Cohort (NHIS–NSC) database
por: Lee, Seung Won, et al.
Publicado: (2022)

Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea
por: Seong, Sang Cheol, et al.
Publicado: (2017)

Cohort Profile: National health insurance service-senior (NHIS-senior) cohort in Korea
por: Kim, Yong Ik, et al.
Publicado: (2019)

Comparison of All-Cause Mortality Between Individuals With COVID-19 and Propensity Score–Matched Individuals Without COVID-19 in South Korea
por: Oh, Tak Kyu, et al.
Publicado: (2021)

Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus
por: Sun, Lin, et al.
Publicado: (2011)

COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Epidemiologic study of epidural analgesia for lung cancer surgery from 2011 to 2018 in South Korea: a National Health Insurance Database cohort study
por: Oh, Tak Kyu, et al.
Publicado: (2022)

Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus
por: Li, Willis, et al.
Publicado: (2021)

Inpatient use of metformin and acarbose is associated with reduced mortality of COVID‐19 patients with type 2 diabetes mellitus
por: Li, Jinghong, et al.
Publicado: (2021)

Investigating the impact of metformin on severity of COVID‐19 in patients with Type 2 diabetes mellitus: Focusing on laboratory findings
por: Taheri, Rana, et al.
Publicado: (2023)

EE197 Efficacy and Economic Impact of Metformin Plus Glibenclamide Treatment During the COVID-19 Pandemic in Ecuadorian Outpatients With Type II Diabetes Mellitus
por: Zambrano, R, et al.
Publicado: (2022)

Musculoskeletal Disorders, Pain Medication, and in-Hospital Mortality among Patients with COVID-19 in South Korea: A Population-Based Cohort Study
por: Oh, Tak-Kyu, et al.
Publicado: (2021)

Association Between Metformin Use and Mortality among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection
por: Ong, Angeli Nicole, et al.
Publicado: (2021)

Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes
por: Wang, Jingya, et al.
Publicado: (2021)

Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus
por: Yen, Fu-Shun, et al.
Publicado: (2023)

The effects of metformin in type 1 diabetes mellitus
por: Beysel, Selvihan, et al.
Publicado: (2018)

Prevalence of mental illness among COVID-19 survivors in South Korea: nationwide cohort
por: Park, Hye Yoon, et al.
Publicado: (2021)

Incidence and Mortality Associated with Cardiovascular Medication among Hypertensive COVID-19 Patients in South Korea
por: Oh, Tak Kyu, et al.
Publicado: (2021)

Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study
por: Jiang, Nan, et al.
Publicado: (2021)

Diabetes, Frequency of Exercise, and Mortality Over 12 Years: Analysis of the National Health Insurance Service-Health Screening (NHIS-HEALS) Database
por: Shin, Woo Young, et al.
Publicado: (2018)

Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?
por: Do, Jun Young, et al.
Publicado: (2021)

COVID-19 and diabetes: Is metformin a friend or foe?
por: Ursini, Francesco, et al.
Publicado: (2020)

Metformin and/or vildagliptin mitigate type II diabetes mellitus induced-oxidative stress: The intriguing effect
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2020)

An Analysis of Utilization and Access From the NHIS: 1984-92
por: Mentnech, Renee, et al.
Publicado: (1995)

Changing patterns of adult asthma incidence: results from the National Health Insurance Service–National Sample Cohort (NHIS-NSC) database in Korea
por: Shin, Ji-Yeon, et al.
Publicado: (2018)

National level data analysis of facial lacerations in Korea using the National Health Insurance Service (NHIS) database
por: Mo, Young Woong, et al.
Publicado: (2021)

Effects of Metformin, Insulin on Hematological Parameters of COVID-19 Patients with Type 2 Diabetes
por: Petakh, Pavlo, et al.
Publicado: (2022)

Effects of Metformin on COVID-19 Patients with Type 2 Diabetes: A Retrospective Study
por: Guo, Ziyu, et al.
Publicado: (2023)

The Effects of COVID-19 on Physicians’ Perceived Ability to Provide Care for Patients With Type II Diabetes Mellitus
por: Abidi, Abbas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_74cbupttffaf0e5d1b5qe45d5e